Clients benefit from complete access, visibility, and control throughout the clinical trial
inVentiv Health Clinical, a leading global supplier of drug development services, will replace its electronic trial master file (eTMF) content management system with Veeva Vault eTMF. Cloud-based, multitenant Vault eTMF delivers secure, instant access to inspection-ready documentation and enables seamless collaboration between inVentiv, trial sponsors, and trial sites worldwide – ultimately helping to speed time to submission and product approval.
“With Vault eTMF, we believe we can provide sponsors with transparency of trial data and enable a richer, more collaborative partnership for improved trial results, including faster time to market,” said Gregg Dearhammer, chief operating officer at inVentiv Health Clinical. “It’s another example of inVentiv delivering innovative global solutions intended to support the development and commercial objectives of our clients.”
Vault eTMF is preconfigured with the Drug Information Association (DIA) TMF Reference Model for a repeatable framework across the enterprise. It supports inspection-readiness with workflow, reports, and dashboards, plus features robust audit trails and an auditor role that supports remote inspection capabilities for sponsors and health authorities.
“Vault eTMF should simplify the entire drug development process, minimizing duplication and improving collaboration, not only across our own teams but with our clients,” explained Rachel Stahler, chief information officer at inVentiv Health Clinical. “And the cloud-based solution should allow us to provide more efficient contract services to our customers in a rapidly changing landscape.”
Vault eTMF also enables shared visibility for participants so that the most current status of trial-related documentation is available at any time. Additionally, Vault Investigator Portal makes collaboration with site personnel easy for faster study start-up and more efficient operations overall. “We are proud to support inVentiv in its drive to provide customers with a highly differentiated service that spans from the clinical phase through commercialization,” concluded Jennifer Goldsmith, vice president of Veeva Vault. “Today, we join forces to break down the walls that hinder strategic collaboration between CROs, sponsors, and trial sites worldwide.”
Vault eTMF and Vault Investigator Portal are part of Veeva Vault, a cloud-based platform and suite of integrated content management applications for the life sciences industry. Vault spans clinical, quality, commercial, and medical – every major part of a life sciences company – giving pharmaceutical, biotechnology, and medical device companies the ability to deploy a single content management system globally.
Helping companies connect securely in the life sciences cloud, Vault provides complete control from start to finish, as well as the easy accessibility, visibility, and agility needed to speed time to market. Vault offers real-time reporting and dashboards; an intuitive, consumer-web interface; and a true multitenant cloud architecture that continuously delivers rapid innovation. Today, more than 100 customers rely upon Veeva Vault to manage some of their most important content. Over the past year alone, Veeva has seen a threefold increase in the number of Vaults utilized by Veeva customers.
Additional Information
• For more information on Veeva Vault eTMF, please visit http://www.veeva.com/rd-content-management/vault-etmf/
• Stay updated on the latest Veeva news:http://www.linkedin.com/company/veeva-systems
• Follow @veevasystems on Twitter: https://twitter.com/veevasystems
• Like Veeva on Facebook: https://www.facebook.com/VeevaSystems
Truqap Combination Shines in Phase III Trial for Prostate Cancer
November 26th 2024Data from the CAPItello-281 trial show Truqap alongside abiraterone and androgen deprivation therapy achieved a statistically significant and clinically meaningful improvement in radiographic progression-free survival.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.